These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16617391)

  • 41. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.
    Calabria FF; Calabria E; Gangemi V; Cascini GL
    Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
    Whone AL; Bailey DL; Remy P; Pavese N; Brooks DJ
    J Nucl Med; 2004 Jul; 45(7):1135-45. PubMed ID: 15235059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computer-aided diagnosis of Parkinson's disease based on [(123)I]FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector machines.
    Oliveira FP; Castelo-Branco M
    J Neural Eng; 2015 Apr; 12(2):026008. PubMed ID: 25710187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT.
    Acton PD; Newberg A; Plössl K; Mozley PD
    Phys Med Biol; 2006 Feb; 51(3):575-85. PubMed ID: 16424582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial clinical experience with [123I]ioflupane scintigraphy in movement disorders.
    Manoharan P; Jamieson S; Bury RF
    Clin Radiol; 2007 May; 62(5):463-71. PubMed ID: 17398272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's disease.
    Pan XB; Wright TG; Leong FJ; McLaughlin RA; Declerck JM; Silverman DH
    J Nucl Med; 2005 Oct; 46(10):1737-44. PubMed ID: 16204725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson's disease patients.
    Zubal IG; Early M; Yuan O; Jennings D; Marek K; Seibyl JP
    J Nucl Med; 2007 Jun; 48(6):857-64. PubMed ID: 17504864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
    Stokkel MP; Dibbets-Schneider P; Koestering E; Dragoiescu C; Blokland KA
    J Nucl Med Technol; 2007 Mar; 35(1):21-6. PubMed ID: 17337653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's disease.
    Ottaviani S; Tinazzi M; Pasquin I; Nothdurfter W; Tomelleri G; Fincati E; Nordera G; Moretto G; Fiaschi A; Smania N; Giorgetti P; Antonini A
    Neurol Sci; 2006 Dec; 27(6):397-401. PubMed ID: 17205224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of a resolution-independent method for the quantification of 123I-FP-CIT SPECT scans.
    Goethals I; Dobbeleir A; Ham H; Santens P; D'Asseler Y
    Nucl Med Commun; 2007 Oct; 28(10):771-4. PubMed ID: 17728606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.
    Marshall VL; Patterson J; Hadley DM; Grosset KA; Grosset DG
    Nucl Med Commun; 2006 Dec; 27(12):933-7. PubMed ID: 17088677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
    Marshall VL; Reininger CB; Marquardt M; Patterson J; Hadley DM; Oertel WH; Benamer HT; Kemp P; Burn D; Tolosa E; Kulisevsky J; Cunha L; Costa D; Booij J; Tatsch K; Chaudhuri KR; Ulm G; Pogarell O; Höffken H; Gerstner A; Grosset DG
    Mov Disord; 2009 Mar; 24(4):500-8. PubMed ID: 19117369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
    Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety, biodistribution and radiation dosimetry of [
    Zhang M; Wang Y; Wang J; Li X; Li B
    EJNMMI Res; 2023 Apr; 13(1):30. PubMed ID: 37029298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor.
    Wang J; Jiang YP; Liu XD; Chen ZP; Yang LQ; Liu CJ; Xiang JD; Su HL
    Acta Neurol Scand; 2005 Dec; 112(6):380-5. PubMed ID: 16281920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.